CEBPB and breast carcinoma: Based on our results, we propose a model that miR-155-mediated depletion of C/EBPβ in breast cancer cells promotes loss of differentiation, invasion and metastasis by shifting the TGF-β response from growth inhibition to EMT (Figure 7).